MedTrace Logo

Risk Stratification for Venous Thromboembolism in Hospitalized Medical Patients

NCT04439383 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1353

Last updated 2022-04-05

No results posted yet for this study

Summary

Hospital-acquired venous thromboembolism (HA-VTE) is one of the leading preventable causes of in-hospital mortality, but prevention of VTE in hospitalized medical patients remains challenging, as preventive measures such as pharmacological thromboprophylaxis (TPX) need to be tailored to individual thrombotic risk.

The broad objective of this project is to improve VTE prevention strategies in hospitalized medical patients by prospectively examining VTE risk factors (including mobility) and comparing existing risk assessment models.

Conditions

  • Venous Thromboembolism
  • Venous Thromboses
  • Pulmonary Embolism
  • Deep Vein Thrombosis
  • Embolism and Thrombosis
  • Mobility Limitation
  • Hospital Acquired Condition

Sponsors & Collaborators

  • Centre Hospitalier Universitaire Vaudois

    collaborator OTHER

  • University Hospital, Geneva

    collaborator OTHER

  • University of Bern

    collaborator OTHER

  • Insel Gruppe AG, University Hospital Bern

    lead OTHER

Principal Investigators

  • Christine Baumgartner, MD, MAS · Inselspital, Bern University Hospital

  • Marie Méan, MD · Centre Hospitalier Universitaire Vaudois, University Hospital of Lausanne

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-06-22
Primary Completion
2022-04-01
Completion
2022-04-01

Countries

  • Switzerland

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04439383 on ClinicalTrials.gov